Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Conditions: Adrenocortical Carcinoma; ACC; Metastatic Adrenocortical Carcinoma Interventions: Radiation: Ablative Radiotherapy; Drug: Pembrolizumab Sponsors: Memorial Sloan Kettering Cancer Center Recruiting

https://clinicaltrials.gov/study/NCT06066333

Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials